“Our scientists will be able to identify emerging viruses with unprecedented speed and precision test new treatments at state of the art facilities and run clinical trials to bring medicines to all Albertans and indeed around the world,” he said.
The remaining approximately $26 million is being earmarked for three other companies:
- $15.5 million to Entos Pharmaceuticals to establish a commercial manufacturing facility in Edmonton.
- $5.6 million to Applied Pharmaceutical Innovation to build an integrated research, commercialization and manufacturing facility.
- $5 million to Northern RNA help expand RNA development.
For that trio of projects, Alberta’s contribution represents about 10 per cent of the total cost of the proposals and the money is contingent on the rest of the funding coming from the federal government or private investors.
Kenney said the province is pushing for Ottawa to provide similar support to what projects in other provinces have received. He said the federal government has been “receptive” but no final decisions have been made.
More to come
View original article here Source